Navigation Links
First Telescopic Implant in Connecticut for Macular Degeneration
Date:3/7/2013

CHESHIRE, Conn., March 7, 2013 /PRNewswire-iReach/ -- Dr. Randolph Kinkade has been recently interviewed on WFSB's Your Health and WTNH's Health News discussing this new technology.  Dr. Kinkade, a Connecticut optometrist, is a founding member of the International Academy of Low Vision Specialists. 

About the size of an eraser tip, the Implantable Miniature Telescope shows promise for some patients who are legal blind due to macular degeneration.  Macular degeneration is the leading cause of permanent vision loss in older Americans. 

"I have been fitting Spectacle Miniature Telescopes in glasses for improving eyesight for over twenty years to help patients improve their ability to read, write and watch television", says Dr. Kinkade. "For certain patients we now have the ability to replace a developing cataract in their eye with a micro-telescope that returns some very useful vision."

The newly FDA and Medicare approved telescope is placed in only one eye.  The telescope implant focuses and enlarged image onto healthier parts of the macula and retina at the back of the eye.  The other eye provides the necessary peripheral or side vision for walking and performing other tasks.

Dr. Kinkade's treatment role is with candidate selection and determining which eye gets the implant.  He also spends considerable time with patients after surgery guiding them to use their new vision.  Dr. Mark Milner will be doing the surgery.

"The implant is not a cure for macular degeneration, but a rehabilitation tool to return some very important vision", says Dr. Kinkade.  "Patients will need to relearn to see and use additional low vision aids to maximize their vision."

For pictures of the telescopic implant, educational videos and information about the treatment program please visit <
'/>"/>

SOURCE Low Vision Consulting
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Thoratec Schedules First Quarter Conference Call, Webcast
3. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
4. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
7. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
8. Insmed to Host 2012 First Quarter Earnings Conference Call
9. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
10. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  A new analysis of Centers for Medicare ... data shows that 81 percent of seniors chose lower-cost ... discounts at certain pharmacies. The findings were released by ... are now the foundation of Medicare Part D," said ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... both ethical and practical grounds, direct programming is ... pluripotent stem,cells.", WASHINGTON, Nov. 20 Two ... Cell unveil a proven way to,generate patient-matched human ... use of human embryos or human or animal ...
... of circulating cancer cells in 40,billion blood cells, ... WARREN, N.J., Nov. 20 Veridex, LLC ... (FDA) has granted an,expanded clearance for the CellSearch(TM) ... monitoring of metastatic colorectal cancer. CellSearch is currently,approved ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 2FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 4
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... a state of serious impairments in both learning ability ... one of the most prevalent conditions in child psychiatry, ... adulthood. ADHD is conservatively estimated to occur in 3,07,5% ... permissive criteria yield estimates of up to 17% (Barbaresi ...
... Just one week after,Cover All Pennsylvanians, the ... the General Assembly, Governor Edward G.,Rendell today visited ... "Tour to,Insure." The five-day, nine-stop tour has highlighted ... coverage. The Lehigh Valley has nearly 37,000,uninsured adults., ...
... no difference in motorists, reaction times , , SATURDAY, Oct. ... pain medications such as morphine does not impair a ... at Rush University Medical Center in Chicago compared two ... morphine and 49 who weren,t taking any pain medication. ...
... Holdings, Inc. (Nasdaq: NHWK ), a leading provider ... today announced that,it will host a conference call on ... to review the company,s third quarter results. Conference ... call will be held on Wednesday, October,31, 2007 at ...
... Medical Injustice, Will Challenge,Corporate-Backed Proponents of "Health Courts", ... Dale Nance, co-author of the groundbreaking new report ... the featured speakers at a,patient safety forum in ... debate the merits and weaknesses of the health ...
... SAN DIEGO, Oct. 12 MediKeeper,( http://www.medikeeper.com ), ... and wellness industry, has closed its Series A ... MediKeeper was started in 2003 by a ... of making medical records secure, mobile,and accessible online. ...
Cached Medicine News:Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3Health News:Governor Rendell's 'Tour to Insure' Urges Passage of Plan to Give Access to Affordable Health Insurance 2Health News:Governor Rendell's 'Tour to Insure' Urges Passage of Plan to Give Access to Affordable Health Insurance 3Health News:Morphine Painkillers Won't Impair Driving 2Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2
Lombart clip-on occluder...
Long handle occluder - Black...
6 inch hand held occlcuder with 49 holes...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Medicine Products: